{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:36:09Z","timestamp":1793262969255,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T00:00:00Z","timestamp":1638230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Little is known about patients with sickle cell disease (SCD) who require intensive care unit (ICU) admission. The goals of this study were to assess outcomes in patients admitted to the ICU for acute complications of SCD and to identify factors associated with adverse outcomes. This multicenter retrospective study included consecutive adults with SCD admitted to one of 17 participating ICUs. An adverse outcome was defined as death or a need for life-sustaining therapies (non-invasive or invasive ventilation, vasoactive drugs, renal replacement therapy, and\/or extracorporeal membrane oxygenation). Factors associated with adverse outcomes were identified by mixed multivariable logistic regression. We included 488 patients admitted in 2015\u20132017. The main reasons for ICU admission were acute chest syndrome (47.5%) and severely painful vaso-occlusive event (21.3%). Sixteen (3.3%) patients died in the ICU, mainly of multi-organ failure following a painful vaso-occlusive event or sepsis. An adverse outcome occurred in 81 (16.6%; 95% confidence interval [95% CI], 13.3%\u201319.9%) patients. Independent factors associated with adverse outcomes were low mean arterial blood pressure (adjusted odds ratio [aOR], 0.98; 95% CI 0.95\u20130.99; <jats:italic>p<\/jats:italic>\u2009=\u20090.027), faster respiratory rate (aOR, 1.09; 95% CI 1.05\u20131.14; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), higher haemoglobin level (aOR, 1.22; 95% CI 1.01\u20131.48; <jats:italic>p<\/jats:italic>\u2009=\u20090.038), impaired creatinine clearance at ICU admission (aOR, 0.98; 95% CI 0.97\u20130.98; <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), and red blood cell exchange before ICU admission (aOR, 5.16; 95% CI 1.16\u201322.94; <jats:italic>p<\/jats:italic>\u2009=\u20090.031). Patients with SCD have a substantial risk of adverse outcomes if they require ICU admission. Early ICU admission should be encouraged in patients who develop abnormal physiological parameters.<\/jats:p>","DOI":"10.1038\/s41598-021-02437-2","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T17:53:32Z","timestamp":1638294812000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Nationwide retrospective study of critically ill adults with sickle cell disease in France"],"prefix":"10.1038","volume":"11","author":[{"given":"Ma\u00eft\u00e9","family":"Agbakou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armand","family":"Mekontso-Dessap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"Pere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Voiriot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Bourenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Canet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Tamion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud W.","family":"Thille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Argaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Pontis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Quenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Hot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Capellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Aubron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyvan","family":"Razazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Masseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00eblle","family":"Brule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Lascarrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,30]]},"reference":[{"key":"2437_CR1","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware, R. E., de Montalembert, M., Tshilolo, L. & Abboud, M. R. Sickle cell disease. Lancet Lond. Engl. 390, 311\u2013323 (2017).","journal-title":"Lancet Lond. Engl."},{"key":"2437_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1080\/00365510601046557","volume":"67","author":"B Modell","year":"2007","unstructured":"Modell, B. et al. Epidemiology of haemoglobin disorders in Europe: An overview. Scand. J. Clin. Lab. Invest. 67, 39\u201369 (2007).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"2437_CR3","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/S0248-8663(15)60002-9","volume":"36","author":"A Habibi","year":"2015","unstructured":"Habibi, A. et al. Recommandations fran\u00e7aises de prise en charge de la dr\u00e9panocytose de l\u2019adulte\u202f: Actualisation 2015. Rev. M\u00e9d.. Int. 36, S3-84 (2015).","journal-title":"Rev. M\u00e9d.. Int."},{"key":"2437_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1046\/j.1365-2141.2003.04594.x","volume":"123","author":"EA Manci","year":"2003","unstructured":"Manci, E. A. et al. Causes of death in sickle cell disease: An autopsy study. Br. J. Haematol. 123, 359\u2013365 (2003).","journal-title":"Br. J. Haematol."},{"key":"2437_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/sj.thj.6200147","volume":"3","author":"V Perronne","year":"2002","unstructured":"Perronne, V. et al. Patterns of mortality in sickle cell disease in adults in France and England. Hematol. J. 3, 56\u201360 (2002).","journal-title":"Hematol. J."},{"key":"2437_CR6","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","volume":"330","author":"OS Platt","year":"1994","unstructured":"Platt, O. S. et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N. Engl. J. Med. 330, 1639\u20131644 (1994).","journal-title":"N. Engl. J. Med."},{"key":"2437_CR7","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1182\/blood-2016-05-716910","volume":"128","author":"K Gardner","year":"2016","unstructured":"Gardner, K. et al. Survival in adults with sickle cell disease in a high-income setting. Blood 128, 1436\u20131438 (2016).","journal-title":"Blood"},{"key":"2437_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.12816\/0003110","volume":"12","author":"QA Tawfic","year":"2012","unstructured":"Tawfic, Q. A. et al. Adult sickle cell disease: A five-year experience of intensive care management in a university hospital in Oman. Sultan Qaboos Univ. Med. J. 12, 177 (2012).","journal-title":"Sultan Qaboos Univ. Med. J."},{"key":"2437_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1080\/14767058.2017.1289511","volume":"31","author":"R Abd Rahman","year":"2018","unstructured":"Abd Rahman, R., DeKoninck, P., Murthi, P. & Wallace, E. M. Treatment of preeclampsia with hydroxychloroquine: A review. J. Matern-Fetal Neonatal Med. 31, 525\u2013529 (2018).","journal-title":"J. Matern-Fetal Neonatal Med."},{"key":"2437_CR10","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1056\/NEJM198005013021803","volume":"302","author":"RP Hebbel","year":"1980","unstructured":"Hebbel, R. P., Boogaerts, M. A., Eaton, J. W. & Steinberg, M. H. Erythrocyte adherence to endothelium in sickle-cell anemia. A possible determinant of disease severity. N. Engl. J. Med. 302, 992\u2013995 (1980).","journal-title":"N. Engl. J. Med."},{"key":"2437_CR11","doi-asserted-by":"publisher","first-page":"c179","DOI":"10.1159\/000339789","volume":"120","author":"A Khwaja","year":"2012","unstructured":"Khwaja, A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron 120, c179\u2013c184 (2012).","journal-title":"Nephron"},{"key":"2437_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0196-0644(96)70264-0","volume":"27","author":"EH Gilbert","year":"1996","unstructured":"Gilbert, E. H., Lowenstein, S. R., Koziol-McLain, J., Barta, D. C. & Steiner, J. Chart reviews in emergency medicine research: Where are the methods?. Ann. Emerg. Med. 27, 305\u2013308 (1996).","journal-title":"Ann. Emerg. Med."},{"key":"2437_CR13","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1097\/CCM.0000000000000316","volume":"42","author":"J Cecchini","year":"2014","unstructured":"Cecchini, J. et al. Outcomes of adult patients with sickle cell disease admitted to the ICU: A case series*. Crit. Care Med. 42, 1629\u20131639 (2014).","journal-title":"Crit. Care Med."},{"key":"2437_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/978-1-4612-1694-0_15","volume-title":"Sel Pap Hirotugu Akaike","author":"H Akaike","year":"1998","unstructured":"Akaike, H. Information theory and an extension of the maximum likelihood principle. In Sel Pap Hirotugu Akaike (eds Parzen, E. et al.) 199\u2013213 (Springer, 1998)."},{"key":"2437_CR15","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jcrc.2017.07.032","volume":"42","author":"SA Al Khawaja","year":"2017","unstructured":"Al Khawaja, S. A., Ateya, Z. M. & Al Hammam, R. A. Predictors of mortality in adults with Sickle cell disease admitted to intensive care unit in Bahrain. J. Crit. Care. 42, 238\u2013242 (2017).","journal-title":"J. Crit. Care."},{"key":"2437_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s00134-016-4472-7","volume":"43","author":"A Mekontso Dessap","year":"2017","unstructured":"Mekontso Dessap, A., Fartoukh, M. & Machado, R. F. Ten tips for managing critically ill patients with sickle cell disease. Intensive Care Med. 43, 80\u201382 (2017).","journal-title":"Intensive Care Med."},{"key":"2437_CR17","doi-asserted-by":"publisher","first-page":"587s","DOI":"10.1016\/S0248-8663(00)87629-8","volume":"20","author":"B Godeau","year":"1999","unstructured":"Godeau, B. et al. \u00c9volution et facteurs pronostiques des adultes atteints d\u2019un syndrome dr\u00e9panocytaire majeur lors de leur admission en r\u00e9animation. Rev. M\u00e9d. Int. 20, 587s (1999).","journal-title":"Rev. M\u00e9d. Int."},{"key":"2437_CR18","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1001\/jama.2010.378","volume":"303","author":"DC Brousseau","year":"2010","unstructured":"Brousseau, D. C., Owens, P. L., Mosso, A. L., Panepinto, J. A. & Steiner, C. A. Acute care utilization and rehospitalizations for sickle cell disease. JAMA 303, 1288\u20131294 (2010).","journal-title":"JAMA"},{"key":"2437_CR19","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/pbc.21854","volume":"52","author":"MJ Frei-Jones","year":"2009","unstructured":"Frei-Jones, M. J., Field, J. J. & DeBaun, M. R. Risk factors for hospital readmission within 30 days: A new quality measure for children with sickle cell disease. Pediatr. Blood Cancer 52, 481\u2013485 (2009).","journal-title":"Pediatr. Blood Cancer"},{"key":"2437_CR20","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/ajh.23912","volume":"90","author":"KL Koch","year":"2015","unstructured":"Koch, K. L., Karafin, M. S., Simpson, P. & Field, J. J. Intensive management of high-utilizing adults with sickle cell disease lowers admissions. Am. J. Hematol. 90, 215\u2013219 (2015).","journal-title":"Am. J. Hematol."},{"key":"2437_CR21","first-page":"088506662097877","volume":"20","author":"JL Simonson","year":"2020","unstructured":"Simonson, J. L. et al. Hemoglobin target and transfusion modality for adult patients with sickle cell disease acute chest syndrome. J. Intensive Care Med. 20, 0885066620978770 (2020).","journal-title":"J. Intensive Care Med."},{"key":"2437_CR22","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1164\/rccm.200710-1606OC","volume":"177","author":"A Mekontso Dessap","year":"2008","unstructured":"Mekontso Dessap, A. et al. Pulmonary hypertension and Cor pulmonale during severe acute chest syndrome in sickle cell disease. Am. J. Respir. Crit. Care Med. 177, 646\u2013653 (2008).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2437_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1001\/jama.2014.10517","volume":"312","author":"BP Yawn","year":"2014","unstructured":"Yawn, B. P. et al. Management of sickle cell disease: Summary of the 2014 evidence-based report by expert panel members. JAMA 312, 1033 (2014).","journal-title":"JAMA"},{"key":"2437_CR24","doi-asserted-by":"publisher","first-page":"S162","DOI":"10.1016\/j.revmed.2009.07.001","volume":"30","author":"F Lionnet","year":"2009","unstructured":"Lionnet, F. et al. Recommandations pratiques de prise en charge de la dr\u00e9panocytose de l\u2019adulte. Rev. M\u00e9d. Int. 30, S162-223 (2009).","journal-title":"Rev. M\u00e9d. Int."},{"key":"2437_CR25","unstructured":"Haberkern CM, et al. Cholecystectomy in Sickle Cell Anemia Patients: Perioperative Outcome of 364 Cases From the National Preoperative Transfusion Study 11."},{"key":"2437_CR26","doi-asserted-by":"publisher","first-page":"e2018032","DOI":"10.4084\/mjhid.2018.032","volume":"10","author":"KO Adjepong","year":"2018","unstructured":"Adjepong, K. O., Otegbeye, F. & Adjepong, Y. A. Perioperative management of sickle cell disease. Mediterr. J. Hematol. Infect. Dis. 10, e2018032 (2018).","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"key":"2437_CR27","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1007\/s00134-020-06228-7","volume":"46","author":"J-D Ricard","year":"2020","unstructured":"Ricard, J.-D. et al. Use of nasal high flow oxygen during acute respiratory failure. Intensive Care Med. 46, 2238\u20132247 (2020).","journal-title":"Intensive Care Med."},{"key":"2437_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1471-2369-13-83","volume":"13","author":"J-B Arlet","year":"2012","unstructured":"Arlet, J.-B. et al. Determination of the best method to estimate glomerular filtration rate from serum creatinine in adult patients with sickle cell disease: A prospective observational cohort study. BMC Nephrol. 13, 83 (2012).","journal-title":"BMC Nephrol."},{"key":"2437_CR29","doi-asserted-by":"publisher","first-page":"e2034004","DOI":"10.1001\/jamanetworkopen.2020.34004","volume":"4","author":"LR Zelnick","year":"2021","unstructured":"Zelnick, L. R., Leca, N., Young, B. & Bansal, N. Association of the estimated glomerular filtration rate with vs without a coefficient for race with time to eligibility for kidney transplant. JAMA Netw. Open 4, e2034004\u2013e2034004 (2021).","journal-title":"JAMA Netw. Open"},{"key":"2437_CR30","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1056\/NEJMoa1715971","volume":"379","author":"Y Niihara","year":"2018","unstructured":"Niihara, Y. et al. A phase 3 trial of l-glutamine in sickle cell disease. N. Engl. J. Med. 379, 226\u2013235 (2018).","journal-title":"N. Engl. J. Med."},{"key":"2437_CR31","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJMoa1611770","volume":"376","author":"KI Ataga","year":"2017","unstructured":"Ataga, K. I. et al. Crizanlizumab for the prevention of pain crises in sickle cell disease. N. Engl. J. Med. 376, 429\u2013439 (2017).","journal-title":"N. Engl. J. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02437-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02437-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T17:47:52Z","timestamp":1670089672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-02437-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,30]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["2437"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-02437-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,30]]},"assertion":[{"value":"16 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"JB Lascarrou declares lecture fees from BD and Zoll as a conflict of interest unrelated to this work. None of the other authors has any conflicts of interest to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23132"}}